Dr. Jason Seth Reingold, MD

Dr. Reingold practices at Wellstar North Fulton Medical Center in Roswell, Georgia, part of Wellstar Health System.

Dr. Reingold's NPI, 1639374283, was assigned on June 15, 2007. Dr. Reingold graduated from Emory University School of Medicine in 2004. Dr. Reingold holds Georgia license 064255.

Dr. Reingold's primary practice is Wellstar North Fulton Medical Center, at 3000 Hospital Boulevard, Roswell, GA 30076 in Fulton County. The practice phone is (770) 751-2500.

Dr. Reingold's primary practice is Wellstar North Fulton Medical Center in Roswell, Georgia, part of Wellstar Health System. Dr. Reingold is also affiliated with Northside Hospital Atlanta. Dmand AI also links Dr. Reingold to 3 more hospitals and 1 physician office, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reingold practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Reingold's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Reingold is licensed in Georgia.

CMS data shows 798 Medicare services from Dr. Reingold across 14 procedure codes in 2024, for 139 Medicare patients. Medicare paid $49,223 for them. Every service was in an office.

CMS counts 139 Medicare patients who saw Dr. Reingold in 2024. The largest group is 65 to 74, with 82 patients. 75% of them have high cholesterol, and 71% have high blood pressure. Their average risk score is 0.83, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Reingold's median patient age at 61, with 48% women.

In 2024, Dr. Reingold wrote 494 Medicare Part D claims for 104 patients. 85% of them were for generic drugs. CMS names the drug for 369 of them, across 15 drugs with 11 or more claims each, at $42,538 in total drug cost. In 2023, CMS named 264 claims across 14 drugs.

Dr. Reingold accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Reingold as offering telehealth.

Dmand AI links 4 papers to Dr. Reingold, published from 2010 to 2015. The most frequent topics are Infusions, Intravenous and Sodium Chloride. Dr. Reingold's most frequent co-authors are Abigail Defrees May Khan, MD, Marielle Scherrer-Crosbie, MD, PhD and Thomas Jue-Fuu Wang, MD.

CMS Open Payments shows 420 general payments to Dr. Reingold from 26 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 87% of the total. Novartis Pharmaceuticals Corporation paid the most, $171,287.

Dr. Reingold graduated from Emory University School of Medicine in 2004.